Starboard Value LP, a prominent activist hedge fund, has recently acquired a substantial stake in Pfizer Inc., a leading pharmaceutical giant. According to unnamed sources familiar with the matter, the investment is valued at approximately $1 billion. The news of Starboard Value’s investment in Pfizer has sent ripples through the pharmaceutical industry and financial markets. Known for its aggressive approach and track record of pushing companies to improve their financial performance and shareholder value, Starboard Value’s involvement in Pfizer is
